Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
252.00
Ask:
257.00
Spread: 5.00 (1.984%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Trading Statement

26 Jul 2023 07:00

RNS Number : 1677H
Wilmington PLC
26 July 2023
 

26 July 2023

Wilmington plc

 

Year-end trading update

 

Wilmington plc, (LSE: WIL, 'Wilmington', 'the Group') the provider of data, information, education and training in the global Governance, Risk and Compliance ('GRC') markets, today provides a trading update for the year ended 30 June 2023.

 

Group organic revenue growth is expected to be 9%, with reported revenues in the order of £123.5m (2021: £121.0m). Recurring revenue up 7% underpinned by strong retention rates.

Adjusted* profit before tax (unaudited) from continuing operations is expected to be £24.1m, up 30% on last year. Adjusted profit before tax (unaudited) is likely to be ahead of expectations at £24.3m* (2022: £20.7m), up some 18%.

 

Cash conversion continued to be strong with Group net cash on 30 June 2023 at £42.2m (31 December 2022: £22.9m; 30 June 2022: £20.5m).

 

Wilmington expects to publish its year end results on 25 September 2023.

 

Mark Milner, Chief Executive Officer, commented:

 

"We continue to execute our strategy which has resulted in another year of strong organic revenue and profit growth - our revenues were up by 9% and profits were up by 30%. We have also continued to see good growth in our recurring revenues and strong cash conversion of profits.

 

"Over the last two years, the business has seen a solid growth in its international scale and reach which has resulted in our profits growing in each quarter."

 

*Adjusted profit before tax (PBT) is calculated as PBT after adding back amortisation of intangible assets except computer software and profits/losses on disposals and business closures. Market consensus Adjusted profit before tax is £22.8m.

 

For further information, please contact:

 

Wilmington plc

Mark Milner, Chief Executive Officer

Guy Millward, Chief Financial Officer

 

Meare Consulting

Adrian Duffield

 

 

020 7490 0049

 

 

 

07990 858548

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs close to 1,000 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUVVNRORUBUAR
Date   Source Headline
20th Feb 20237:00 amRNSHalf-year Report
9th Feb 202312:36 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSTotal Voting Rights
24th Jan 202310:30 amRNSNotice of Half Year-End Results
19th Dec 202211:32 amRNSHolding(s) in Company
12th Dec 20227:00 amRNSJoint Broker appointment
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20222:50 pmRNSHolding(s) in Company
1st Dec 20227:00 amRNSTotal Voting Rights
23rd Nov 20223:12 pmRNSResult of AGM
15th Nov 20222:31 pmRNSHolding(s) in Company
17th Oct 202212:11 pmRNSHoling(s) in Company
17th Oct 202212:11 pmRNSHolding(s) in Company
3rd Oct 20225:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSTotal Voting Rights
30th Sep 20224:42 pmRNSSecond Price Monitoring Extn
30th Sep 20224:36 pmRNSPrice Monitoring Extension
29th Sep 20223:43 pmRNSHolding(s) in Company
29th Sep 20223:36 pmRNSIssue of ordinary shares
22nd Sep 20227:00 amRNSFinancial results for the year ended 30 June 2022
31st Aug 20227:00 amRNSNotice of Results
19th Aug 20225:07 pmRNSDirector/PDMR Shareholding
1st Aug 20227:00 amRNSTotal Voting Rights
27th Jul 20227:00 amRNSYear-End Trading Update
1st Jul 20227:00 amRNSTotal Voting Rights
29th Jun 20223:04 pmRNSHolding(s) in Company
14th Jun 20227:00 amRNSTransaction in Own Shares
10th Jun 20224:36 pmRNSPrice Monitoring Extension
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 20227:00 amRNSSave As You Earn Options
16th May 202211:52 amRNSSave As You Earn Options
13th May 20227:00 amRNSSave As You Earn Options
5th May 20229:39 amRNSShare Awards
3rd May 20227:00 amRNSTotal Voting Rights
1st Apr 20227:00 amRNSTotal Voting Rights
15th Mar 20227:00 amRNSTrading impact of face-to-face events
1st Mar 20227:00 amRNSTotal Voting Rights
24th Feb 20227:00 amRNSDirector/PDMR Shareholding
21st Feb 20227:00 amRNSHalf-year Report
14th Feb 202210:06 amRNSHolding(s) in Company
14th Feb 202210:00 amRNSHolding(s) in Company
1st Feb 20227:00 amRNSTotal Voting Rights
27th Jan 20227:00 amRNSTrading Update
24th Dec 202110:59 amRNSAMT Financial Training business sold for £23.4m
17th Dec 20214:40 pmRNSSecond Price Monitoring Extn
17th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20217:00 amRNSTotal Voting Rights
25th Nov 202111:26 amRNSHolding(s) in Company
3rd Nov 202112:14 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.